What is BONSITY?

A trusted anabolic therapy for osteoporosis

The first FDA-approved alternative to FORTEO^® (teriparatide injection), BONSITY builds on more than 20 years of real-world experience with teriparatide.123*

^*Not automatically substituted for FORTEO.

Lower-cost alternative for high-risk patients

BONSITY helps patients build new bone affordably—eligible, commercially insured patients pay as little as $0 through our Savings Program.† That’s important for your patients with osteoporosis at high risk for fracture.

BONSITY delivers results for women and men with osteoporosis.1

See the data

^†Individual costs may vary. Program eligibility and restrictions apply.

Key features of BONSITY1

Active ingredient: Teriparatide

Indications: 3 patient populations

Dosing: 20 mcg once a day

Administration: Subcutaneous injection via single-patient-use pen

BONSITY builds bone for more patients

BONSITY is indicated for 3 patient populations1:

Middle-aged woman with red glasses and short dark hair and a red shirt — Actor portrayal.

Postmenopausal women with osteoporosis at high risk for fracture

Middle-aged man with a mustache wearing a blue plaid shirt — Actor portrayal.

Men with primary or hypogonadal osteoporosis at high risk for fracture

A middle-aged woman with short gray hair in a navy blue sweater wrapping her arms around a middle-aged man in a light blue sweater with a white beard and glasses — Actor portrayals.

Men and women with glucocorticoid-associated osteoporosis who have a high risk for fracture

Use of BONSITY for more than 2 years during a patient's lifetime should only be considered if a patient remains at or has returned to having a high risk for fracture.